SCLEROTIOTIDE_F;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-(ALPHA)-6-OXOHEXA-2,4-DIENOYL-L-ORN)]
Compound with spectra: 1 NMR
![SCLEROTIOTIDE_F;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-(ALPHA)-6-OXOHEXA-2,4-DIENOYL-L-ORN)]](/api/compound/VUKnRqmxOp.png?ph=true&h=300&w=458 "SCLEROTIOTIDE_F;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-(ALPHA)-6-OXOHEXA-2,4-DIENOYL-L-ORN)]")
| SpectraBase Compound ID | VUKnRqmxOp |
|---|---|
| InChI | InChI=1S/C21H32N4O5/c1-14(2)18-21(30)24(4)15(3)19(28)22-12-9-10-16(20(29)25(18)5)23-17(27)11-7-6-8-13-26/h6-8,11,13-16,18H,9-10,12H2,1-5H3,(H,22,28)(H,23,27)/b8-6+,11-7+/t15-,16-,18-/m0/s1 |
| InChIKey | KPPYRCDQUDIYQD-CAYKZORVSA-N |
| Mol Weight | 420.5 g/mol |
| Molecular Formula | C21H32N4O5 |
| Exact Mass | 420.23727 g/mol |
| Enantiomer InChIKey | KPPYRCDQUDIYQD-KANBGSFMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
ASPOCHRACIN
SCLEROTIOTIDE_B;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]
SCLEROTIOTIDE_H;THREO-(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-6,7-DIHYDROXYOCTA-2,4-DIENOYL-L-ORN)]
SCLEROTIOTIDE_C;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-LYS)]
DRAGONAMIDE_C
dl-Valinamide, N-methyl-N-(1-oxodecyl)glycyl-N-methyl-dl-leucyl-N-formyl-N,N2-dimethyl-
SCLERAMIDE
CYCLO-(L-N-ME-PHE-L-ILE)2
DIHYDRO-TENTOXIN
HC-TOXIN-2;CYCLO-[ALA-GLY-(2-AMINO-8-OXO-9,10-EPOXY-DECANOYL)-PRO]
| Title | Journal or Book | Year |
|---|---|---|
| Cyclic Tripeptides from the Halotolerant Fungus Aspergillus sclerotiorum PT06-1 | Journal of Natural Products | 2010 |